Saturday - December 27, 2025
Technical University of Munich: Study Shows Additional Benefits of Semaglutide and Tirzepatide
November 10, 2025
MUNICH, Germany, Nov. 10 (TNSjou) -- The Technical University of Munich issued the following news:

* * *

Study shows additional benefits of semaglutide and tirzepatide

Obesity drugs improve heart health

*

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this in using . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products